Network pharmacology: curing causal mechanisms instead of treating symptoms

C Nogales, ZM Mamdouh, M List, C Kiel… - Trends in …, 2022 - cell.com
For complex diseases, most drugs are highly ineffective, and the success rate of drug
discovery is in constant decline. While low quality, reproducibility issues, and translational …

On the clinical pharmacology of reactive oxygen species

AI Casas, C Nogales, HAM Mucke, A Petraina… - Pharmacological …, 2020 - Elsevier
Reactive oxygen species (ROS) have been correlated with almost every human disease. Yet
clinical exploitation of these hypotheses by pharmacological modulation of ROS has been …

Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's …

J Fang, P Zhang, Y Zhou, CW Chiang, J Tan, Y Hou… - Nature Aging, 2021 - nature.com
We developed an endophenotype disease module-based methodology for Alzheimer's
disease (AD) drug repurposing and identified sildenafil as a potential disease risk modifier …

Network-based machine learning in colorectal and bladder organoid models predicts anti-cancer drug efficacy in patients

JH Kong, H Lee, D Kim, SK Han, D Ha, K Shin… - Nature …, 2020 - nature.com
Cancer patient classification using predictive biomarkers for anti-cancer drug responses is
essential for improving therapeutic outcomes. However, current machine-learning-based …

Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF-κB pathway

Y Wei, Y Fan, Y Ga, Y Zhang, J Han, Z Hao - Phytomedicine, 2021 - Elsevier
Background Shaoyao decoction (SYD), a traditional Chinese medicine prescription that
originated in the **-Yuan Dynasty, has shown effects in treating ulcerative colitis. However …

From single drug targets to synergistic network pharmacology in ischemic stroke

AI Casas, AA Hassan, SJ Larsen… - Proceedings of the …, 2019 - National Acad Sciences
Drug discovery faces an efficacy crisis to which ineffective mainly single-target and symptom-
based rather than mechanistic approaches have contributed. We here explore a mechanism …

In-silico drug repurposing study predicts the combination of pirfenidone and melatonin as a promising candidate therapy to reduce SARS-CoV-2 infection progression …

L Artigas, M Coma, P Matos-Filipe, J Aguirre-Plans… - PLoS …, 2020 - journals.plos.org
From January 2020, COVID-19 is spreading around the world producing serious respiratory
symptoms in infected patients that in some cases can be complicated by the severe acute …

High-content phenotypic and pathway profiling to advance drug discovery in diseases of unmet need

RE Hughes, RJR Elliott, JC Dawson, NO Carragher - Cell chemical biology, 2021 - cell.com
Conventional thinking in modern drug discovery postulates that the design of highly
selective molecules which act on a single disease-associated target will yield safer and …

NOX5-induced uncoupling of endothelial NO synthase is a causal mechanism and theragnostic target of an age-related hypertension endotype

MH Elbatreek, S Sadegh, E Anastasi, E Guney… - PLoS …, 2020 - journals.plos.org
Hypertension is the most important cause of death and disability in the elderly. In 9 out of 10
cases, the molecular cause, however, is unknown. One mechanistic hypothesis involves …

[HTML][HTML] Translating precision medicine for autism spectrum disorder: A pressing need

L Pérez-Cano, SA Chenlo, R Sabido-Vera, F Sirci… - Drug discovery today, 2023 - Elsevier
Autism spectrum disorder (ASD) is a heterogenous group of neurodevelopmental disorders
(NDDs) with a high unmet medical need. Currently, ASD is diagnosed according to behavior …